90732
Medical code 90732 refers to the administration of the pneumococcal vaccine, specifically the 23-valent pneumococcal polysaccharide vaccine (PPSV23). This vaccine is typically given to protect against pneumonia and other infections caused by pneumococcal bacteria. It's commonly administered to certain high-risk populations, including older adults and individuals with specific health conditions. The code is used for billing and insurance purposes to indicate the specific vaccine administered.
no
Influenza vaccine, intramuscular
Immunization administration; each additional vaccine
Pneumococcal polysaccharide disease is caused by a bacteria. It can be deadly but a vaccine was developed to head off the disease before it starts. The vaccine works when a small amount of the bacteria is injected into the patient and his or her immunity works against the disease, causing immunity.
The procedure code 90718, which was previously used for the administration of the Human Papillomavirus (HPV) vaccine, has been replaced by code 90651. Code 90651 specifically refers to the HPV vaccine for individuals aged 9 through 45 years. It is important to stay updated with coding resources or the American Medical Association (AMA) for any changes in vaccine codes.
The CPT procedure code for vaccine administration for an 18-month-old is typically 90460 for the first vaccine and 90461 for each additional vaccine administered on the same day. These codes are used for documenting the administration of vaccines to patients aged 18 months or younger. Always check the latest coding guidelines or updates, as codes may change.
No, the "pneumonia vaccine" is to protect against several types of pneumonia that are common and will not protect against the A-H1N1/09 virus. See related questions below.
DefinitionThe pneumococcal conjugate vaccine helps protect against mild and severe infections due to the bacteria Streptococcus pneumoniae. This bacteria frequently causes ear infections, meningitis, and pneumonia in children.See also: Pneumococcal polysaccharide vaccineInformationThe pneumococcal conjugate vaccine is an inactivated-bacteria vaccine, which means it uses dead bacteria to teach the immune system to recognize and fight active bacteria.This vaccine effectively prevents childhood illnesses caused by Streptococcus pneumoniae.WHO SHOULD GET THIS VACCINEChildren should receive four doses of the vaccine, one dose each at the following ages:2 months4 months6 months12 - 15 monthsPneumococcal conjugate vaccine is not the same as the pneumococcal polysaccharide vaccine, which is used in children over age 2 and in adults. For information on that vaccine, see: Pneumococcal polysaccharide vaccineRISKS AND SIDE EFFECTSMost people have no or only minor side effects from the pneumococcal conjugate vaccine. Pain and redness at the injection site can occur. As is the case with any drug or vaccine, there is a small risk of an allergic reaction, more serious reactions, or even death.Watch for and be familiar with how to treat minor side effects such as low-grade fever or tenderness at the injection site.CONSIDERATIONSIf your child has a fever or an illness that is more serious than a cold, the vaccine may be withheld or delayed.CALL YOUR HEALTH CARE PROVIDER IF:Call your health care provider if moderate or serious side effects appear after this vaccine has been given, or if you have any questions or concerns.Call your health care provider if you are not sure if the pneumococcal conjugate vaccine should be delayed, withheld, or only given to a specific person.ReferencesAmerican Academy of Pediatrics Committee on Infectious Diseases. Recommended immunization schedules for children and adolescents -- United States, 2008. Pediatrics. 2008;121(1):219-220.Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years---United States, 2009. MMWR. January 2, 2009;57(51&52);Q1-Q4.
Pneumococcal polysaccharide vaccine (PPSV) is generally not recommended for all children. It is primarily indicated for children aged 2 years and older who are at increased risk for pneumococcal disease due to certain medical conditions. The routine vaccination schedule for children typically involves the pneumococcal conjugate vaccine (PCV) instead. Consultation with a healthcare provider is essential to determine the appropriate vaccination based on individual health needs.
The PVC (Pneumococcal Conjugate Vaccine) is made by combining polysaccharides from the capsule of Streptococcus pneumoniae bacteria with a carrier protein. The polysaccharides are purified and then conjugated to the protein, enhancing the immune response. This process stimulates the body to produce antibodies against the bacteria, providing protection against pneumococcal diseases. The vaccine undergoes rigorous testing for safety and efficacy before being approved for public use.
90658 is an flu vaccine code used for children aged 3 years and above 3 years.